our laboratory (mean 2060 mU/I; range 4504050 mU/I). No patient had evidence of a prolactin secreting macroadenoma on computed tomography. No other endocrine abnormality was found after full endocrine assessment, and treatment was initiated with lysuride, the starting dose of 0-1 mg being taken at night in the middle ofa snack. The dose oflysuride was then gradually increased by 0 1 mg in the middle of food until normoprolactinaemia was achieved, unacceptable side effects ensued, or a daily dose of 1-2 mg was reached. Patients seeking pregnancy were instructed to stop treatment within 48 hours of missing a period. Lysuride was the first dopamine agonist used in 22 patients, and in two it was introduced becauseofunacceptable sideeffectswithbromocriptine. Treatmentwascontinued for one to 40 months (mean 5 4 months).
In 23 cases lysuride (mean dose 04 mg daily; range 0-1-1-2 mg/day) appreciably reduced the serum prolactin concentration, values becoming normal in eight cases (figure) Hypercalcaemia is often an incidental finding during biochemical investigation, being found in 1I 1% of the general population' and 3-6% of patients in hospital.2 The most common cause is primary hyperparathyroidism. Ten per cent ofpatients with sarcoidosis have hypercalcaemia, but hypercalciuria is much more common.3 It is therefore possible that ,B antagonists may be given to some patients with unsuspected disturbances in their calcium metabolism. I report on the effects of the , antagonist atenolol on the calcium balance of two patients.
Case reports
Case 1-A 61 year old man with angina was treated with atenolol 100 mg/day. He had been under investigation for two years for mild but persistent asymptomatic hypercalcaemia, which was thought to be due to primary hyperparathyroidism. He was not taking any' other drugs.
Case 2-A 51 year old woman with diabetes controlled by diet and with a diagnosis ofsarcoidosis was prescribed atenolol 100 mg/day for hypertension. She was not taking any other drugs. After three weeks atenolol was stopped because of side effects.
The table shows the results of measurements of plasma concentration and urinary excretion of calcium and phosphate in both cases.
Comment
In both these cases atenolol caused decreases in plasma calcium concentration and urinary calcium excretion and an increase in plasma phosphate concentration. These changes appeared to be reversible in the patient studied after withdrawal of atenolol (case 2) and have not previously been reported.
It is not kno'wn how atenolol caused these changes. 'l'he non-selective antagonist propranolol can reduce basal parathyroid hormone concentrations,4 and'it has been successful in treating a case of hyperparathyroidism.5 Different mechanisms are responsible for hypercalcaemia in hyperparathyroidism and in sarcoidosis, which suggests that atenolol may have more than one action.,
The recent observation that untreated asymptomatic hypercalcaemia constitutes a risk factor for premature death suggests that further studies on the effects ofatenolol on calcium 'metabolism are indicated.'
In summary, the results show that atenolol may have an affect on calcium and phosphate metabolism.' Although the mechanisms, of action remain uilown, in cases where plasma concentration and urinary excretion of calcipm and phosphate are measured the effects of any concomitant use of 13 antagonists must be considered.
I am grateful to Dr W B Thomson for allowing me to report these cases. Case report A 24 year old man was cleaning a vat containing silver cyanide when he was overcome by fumes and collapsed into several inches of slurry. On arrival in the casualty department 15 minutes later he was unresponsive, apnoeic, and hypotensive. His skin was brick red, which is compatible with cyanide toxicity. After resuscitation 300 mg of dicobalt edetate was given at one, two, three, and seven minutes. Spontaneous respiration resumed, although he remained haemodynasnically unstable. Twenty four hours after admission urine output and blood pressure were satisfactory. Electroencephalograms obtained at this time and 48 hours after admission showed no cerebral activity. As he remained haemodynamically stable and blood cyanide values were rapidly falling to nontoxic concentrations (table) the possibility oforgan donation was considered. The criteria for brain death were satisfied four days after admission, and shortly afterwards donor nephrectomy was undertaken. Serum urea and creatinine concentrations were 10-7 mmol/l and 146 stmol/l respectively on the day the kidneys were removed. Urine output during the 24 hours before the operation was 2883 ml.
The recipients were a suitably matched 43 year old man and 52 year old woman. ,umol/l and 20-9 mmol/l and 167 ltmol/l, respectively.
We believe that this is the first report of successful organ transplantation from a donor dying of cyanide poisoning. Cyanides are rapidly absorbed by all tissues, particularly the lungs.' The cyanide ion combines intracellularly with the ferric ion in cytochrome oxidase, forming an inactive complex which blocks the electron transport system and cellular utilisation ofoxygen. In sufficient dosage death is caused by respiratory failure because the nerve cells of the respiratory centre are particularly vulnerable to lack of oxygen.
Blood cyanide concentrations of 8 pmol/l indicate substantial intoxication and a value of more than 38 .tmol/l is usually fatal.2 It has been suggested that if cardiac output and respiration can be maintained, up to half of the cyanide in the circulation can be metabolised within one hour of exposure.3 Eighty per cent of cyanide is detoxified by the liver enzyme rhodanase to non-toxic thiocyanate, which is excreted in the urine.4 The high concentration of cyanide recorded during the first three hours in this case probably indicate continuing enteric or percutaneous absorption. Despite these values the patient's kidneys were successfully used for transplantation. This suggests that although victims offatal cyanide poisoning suffer irreversible brain injury as a result of depression of the respiratory centre, other organs are only reversibly damaged and may be considered for transplantation. Careful evaluation of every patient dying of irreversible brain injury should increase the number of potential donors.
